PubMed · 1994 · 13 citations · 0 references
MedicineOncologyPathologyCervical DiseaseMolecular VirologyVirologyCervical CancerCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyHuman Papillomavirus InfectionOncogenic VirusesDna In Situ HybridizationDysplastic ChangesDysplastic Lesion ProgressionDysplastic LesionsGenital InfectionsHpv GenotypesHpv PersistenceHuman Papillomavirus Prognosis
The efficacy of treatment of HPV infections was evaluated in 14 HIV-1 seropositive women. Disease evolution was evaluated at follow-up examinations, and findings were compared to those in 14 historic HIV-negative women who had received similar treatment. HPV sequences were demonstrated by Southern blot in 13/14 HIV-positive women and by in situ hybridization in 5/13 HIV-negative women. Types 6/11, 16, and 31/33/35 were equally distributed in both groups; type 18 was never detected. In all but one case, the same viral type was present in different lesions, and in recurrences. Among the HIV-positive women, integration of viral sequences had occurred in the dysplastic lesions in 2 of the 3 HPV-16-positive cases; both cases showed progression to carcinoma in situ within 1 to 2 years. Despite comparable treatment, the HIV-positive women showed lesion persistence or progression, while all HIV-negative women experienced regression.